United States District Court for the Southern District of New York Grants Preliminary Injunction Against FDA for Regulations of Off-Label Promotion - Amarin Pharma, Inc. v. U.S. Food & Drug Admin.

The article reports the decision of the U.S. District Court for the Southern District of New York in the case "Amarin Pharma Inc. v. U.S. Food & Drug Administration (FDA)" in which the court grants preliminary injunction against FDA for regulations of off-label promotion. Topics discussed include the U.S. Supreme Court's decision in Sorrell v. IMS Health Inc.; laws concerning pharmaceutical marketing; and laws preventing infringement of free speech rights.